Continuous versus cyclical transdermal oestrogen replacement therapy in postmenopausal women: Effects on lipoprotein(a) and nitric oxide levels

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 41, Issue 4, 2001, Pages 447-449

  Serin, Ibrahim Serdar ^a   Aygen, Ercan M ^a   Basbug, Mustafa ^a   Saraymen, Recep ^b   Narin, Figen ^b   Tayyar, Mehmet ^a  

^a ERCIYES UNIVERSITY   (Turkey)

^b Department of Biochemistry Kayseri ^*  (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; FARLUTAL DEVA; LIPOPROTEIN A; MEDROXYPROGESTERONE ACETATE; NITRIC OXIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ESTROGEN THERAPY; FEMALE; HUMAN; HUMAN TISSUE; LIPOPROTEIN BLOOD LEVEL; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS;

EID: 0035178397     PISSN: 00048666     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1479-828X.2001.tb01328.x     Document Type: Article

References (16)

1. Are changes in lipoproteins during HRT important?
2. Cardioprotective effects of ovarian hormones
3. Cardiovascular implications of estrogen replacement therapy
4. Cardioprotective effects of individual conjugated equine estrogens through their possible modulation of insulin resistance and oxidation of low density lipoprotein
5. Lipoprotein(a) as a determinant of coronary heart disease in young women
6. Effects of oral and transdermal hormone replacement therapy on lipoprotein(a) and lipids: A randomized controlled trial
7. The effects of estrogen replacement therapy with or without progestogen on the fibrinolytic system and coagulation inhibitors in postmenopausal status
8. Effects of short-term transdermal estradiol administration on plasma levels of nitric oxide in postmenopausal women
9. Effects of estrogen replacement therapy on peripheral vasomotor function in postmenopausal women
10. Estrogen increases endothelial nitric oxide by a receptor mediated system
11. Acute effects of transdermal estradiol administration on plasma levels of nitric oxide in postmenopausal women
12. The calcium-dependent nitric oxide production of human vascular endothelial cells in preeclampsia
13. Effects of postmenopausal hormone replacement therapy on lipoprotein(a) concentration
14. Effects of hormone replacement therapy on cardiovascular risk factors in postmenopausal women
15. The long-term effects of oral and transdermal postmenopausal hormone replacement therapy on nitric oxide, endothelin-1, prostacyclin, and tromboxane
16. Circulating nitric oxide (nitrit/nitrate) levels in postmenopausal women substituted with 17-β estradiol and norethisterone acetate: A two-year follow-up study